Gilles Grangé

Dr. Gilles Grangé


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
GGGilles Grangé
Gilles Grangé
IBI. Berlin
I. Berlin
FBF. Bretelle
F. Bretelle
CBC. Bertholdt
C. Bertholdt
PBP. Berveiller
P. Berveiller
GLG. Legendre
G. Legendre

Verified
Journal Article
Open access
PDF file
JGJean Guibourdenche
Jean Guibourdenche
MLMarie-Clémence Leguy
Marie-Clémence Leguy
GPGuillaume Pidoux
Guillaume Pidoux
MHMarylise Hebert-Schuster
Marylise Hebert-Schuster
CLChristelle Laguillier
Christelle Laguillier
VTVassilis Tsatsaris
Vassilis Tsatsaris
It is now well established that maternal serum markers are often abnormal in fetal trisomy 21. Their determination is recommended for prenatal screening and pregnancy follow-up. However, mechanisms leading to abnormal maternal serum levels of such markers are still debated. Our objective was to help clinicians and scientists unravel the pathophysiology of these markers via a review of the main studies published in this field, both in vivo and in vitro, focusing on the six most widely used markers (hCG, its free subunit hCGβ, PAPP-A, AFP, uE3, and inhibin A) as well as cell-free feto–placental DNA. Analysis of the literature shows that mechanisms underlying each marker’s regulation are multiple and not necessarily directly linked with the supernumerary chromosome 21. The crucial involvement of the placenta is also highlighted, which could be defective in one or several of its functions (turnover and apoptosis, endocrine production, and feto–maternal exchanges and transfer). These defects were neither constant nor specific for trisomy 21, and might be more or less pronounced, reflecting a high variability in placental immaturity and alteration. This explains why maternal serum markers can lack both specificity and sensitivity, and are thus restricted to screening.

1 April 2020 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
MLMarie Amélie LEQUOY
Marie Amélie LEQUOY
SBS. Beaudoin
S. Beaudoin
LGL. Galmiche
L. Galmiche
GGGilles Grangé
Gilles Grangé